Haxone-T 562.5 Injection
Marketer
Hiya Lifesciences Pvt Ltd
Salt Composition
Ceftriaxone (500mg) + Tazobactum (62.5mg)
Overview Haxone-T 562.5 Injection
Combiflox 562.5mg injection is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism inhibits microbial proliferation, thus curbing infection spread. Administration must be strictly under a physician's guidance; adherence to the prescribed schedule is crucial for efficacy. Complete the full treatment course, regardless of symptom improvement; premature cessation may compromise its effectiveness. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Escalation of any side effect warrants immediate medical consultation. Allergic reactions (skin rashes, pruritus, edema, dyspnea) require urgent medical attention. Inform your doctor about any concurrent medications before commencing treatment. Pregnant or lactating individuals should seek medical counsel prior to use. Alcohol consumption should be avoided due to potential additive drowsiness. While it generally doesn't affect driving ability, refrain from driving if drowsiness or dizziness occurs. Sufficient rest, balanced nutrition, and ample hydration are recommended for optimal recovery. Monitoring may involve laboratory tests to assess the medication's impact.
Primary Ingredients of Haxone-T 562.5 Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Haxone-T 562.5 Injection
Infections caused by bacteria
Major Benefits of Haxone-T 562.5 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Haxone-T 562.5 Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Haxone-T 562.5 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Haxone-T 562.5 Injection works:
Ceftriaxone and Tazobactum, the components of Haxone-T 562.5 Injection, act synergistically. Ceftriaxone, an antibiotic, disrupts bacterial cell wall synthesis, hindering bacterial survival. Tazobactum, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thus bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Haxone-T 562.5 Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Haxone-T 562.5 is generally deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; yet, clinical data in humans are scarce.
Breast feedingCAUTION
Administering Haxone-T 562.5 Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Haxone-T 562.5 Injection can cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these side effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Haxone-T 562.5 Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
Exercise caution when administering Haxone-T 562.5 Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Haxone-T 562.5 Injection is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Haxone-T 562.5 Injection :
Should you forget a scheduled Haxone-T 562.5 Injection, seek your physician's advice.
Facts to Know About Haxone-T 562.5 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently